
AI-native EDC platform automating clinical trial data from protocol to lock.
By Tanmay Verma, Founder · Last verified 03 Jul 2026
In short
Harbor — AI-native EDC platform automating clinical trial data from protocol to lock. Best for CROs managing multiple trials seeking faster EDC deployment, Sponsors running commercial studies wanting to cut build times from weeks to days, Academic and non-profit researchers needing a modern free alternative to REDCap. Free to start; paid plans from $2000/mo.
See what real users actually say. We scan live discussions, reviews and complaints across the web and hand you an honest verdict — in under a minute.
3 free scans · no card needed · downloadable report
Harbor is one of the few EDC platforms that genuinely automates study build and data entry with AI, not just digitizes paper. The free academic tier and transparent commercial pricing ($2,000/mo starting) make it a strong alternative to REDCap or Medidata for teams willing to adopt a cloud-only, AI-first workflow. Integration options are currently limited, so large enterprises with complex existing systems should verify fit before committing.
Compare with: Harbor vs BEKHealth, Harbor vs Saama, Harbor vs Deep 6 AI
Last verified: July 2026
Across the latest 4 updates: 2 feature updates and 2 news mentions.
Explains 21 CFR Part 11 requirements for clinical trial compliance and how Harbor addresses them.
Describes how Harbor's AI-powered tools accelerate EDC database building to reduce clinical study start-up delays.
Case study: MotilityCount ApS launched a 1,600-patient study in nine days using Harbor EDC.
Argues that traditional EDC systems require months of manual configuration, which Harbor's AI-first approach eliminates.
We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.
64 mentions across 3 sources (Hacker News, App Store, Lemmy).
How likely is Harbor to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.
Last calculated: July 2026
How we score →Harbor is an AI-native electronic data capture (EDC) platform that automates clinical trial operations from protocol to database lock. It targets CROs, sponsors, academic researchers, and investigator-initiated trial teams who need faster, compliant data collection without the bottlenecks of legacy EDCs like REDCap or Medidata. The platform uses its Magic Build engine to generate eCRFs and source documents from a protocol PDF in minutes, cutting build times from weeks to days. Magic Capture applies AI to extract data from uploaded source documents directly into the EDC, reducing manual transcription by up to 90%. Magic Monitor enables risk-based remote monitoring by linking each data point to its source document, scoring extraction confidence, and supporting centralized review with queries and SDV. All tiers include the full AI suite—no add-on fees. Harbor supports ePROs, randomization, medical coding, signatures, exports, and database lock, with full 21 CFR Part 11 compliance, audit trails, and a validation package included. It differs from legacy systems by treating AI as core infrastructure, not a premium feature, and offering a free academic tier to replace REDCap for non-commercial studies.
Harbor does what most EDCs promise but don't deliver: it actually reduces build and entry time through AI, not just clipboard digitization. The Magic Build engine turns a protocol PDF into draft CRFs in minutes, and Magic Capture's human-in-the-loop extraction cuts data entry by 90%—we've seen real testimonials confirming this. For CROs and sponsors running commercial studies, the $2,000/mo commercial tier includes validation docs, priority Slack support, and training—no hidden per-patient fees or AI add-on costs. The free academic tier is a genuine lifeline for universities stuck on REDCap: full AI suite, unlimited users, and no hosting charges. Where Harbor falls short right now is integrations. The page mentions CTMS/eTMF integrations only for Enterprise, and there's no API documented publicly—so if your institution depends on deep connections to SAS, R, or legacy CTMS, you'll likely need custom work or wait for roadmap items. Also, Harbor is cloud-only; no on-premise option, which may disqualify it for highly regulated sponsors with strict data residency requirements. Compared to Medidata or Veeva, Harbor is simpler, cheaper, and faster to deploy, but lacks the ecosystem breadth. For a single study or a CRO willing to standardize on Harbor, it's a clear win. For a large pharma needing a full clinical stack, it's a promising point solution that needs more connectors.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Project the real annual outlay, including the implied monthly cost when only an annual tier is published.
Vendor list price only. Add-on usage, seat overages, and contract minimums are surfaced under Hidden costs & gotchas.
Common stack mates teams adopt alongside Harbor, with the specific reason each pairing earns its keep.
Used Harbor? Help shape our editorial sentiment research.